Abstract
Congenital dyserythropoietic anemia type I is an autosomal recessive disorder associated with macrocytic anemia, ineffective erythropoiesis, iron overloading and characterized by abnormal chromatin ultrastructure in erythroblasts such as internuclear chromatin bridges, spongy heterochromatin and invagination of the nuclear membrane. A 58-year-old Causasian man with chronic hemolytic anemia, heterozygous for β + -globin IVS1, nt110 G>A mutation (causing abnormal alpha:beta globin chain ratio) showed clinical, laboratory and hematological features suggesting diagnosis of CDA1. Sequence analysis of CDA-related genes revealed compound heterozygosity for two novel mutations in the CDAN1 gene: a frameshift mutation 3367 del 4 (TTAG) in exon 25 and a missense mutation c.1811 G>T in exon 11 causing an aminoacid change from glycine to valine at codon 565 (G565V). One of the propositus’ brothers showed the same gene mutations. As the CDA1 can mimic thalassemia, a frequent misdiagnosis is possible especially in countries where the prevalence of thalassemia is high. A strong clinical suspicion in patients who do not reveal a clear genetic basis for presumed thalassemia may help clinch the correct diagnosis.
This is a preview of subscription content, log in via an institution to check access.
References
Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H et al (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71:1467–1474
Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940
Liljeholm M, Irvine AF, Wikberg AL, Norberg A, Month S, Sandström H et al (2013) Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood 121(23):4791–4799
Wickramasinghe SN (1997) Dyserythropoiesis and congenital dyserythropoietic anemias. Br J Haematol 98:785–797
Tamary H, Shalev H, Luria D, Shaft D, Zoldan M, Shalmon L et al (1996) Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 87:1763–1770
Iolascon A, Esposito MR, Russo R (2012) Clinical aspects and pathogenesis of CDAs: from morphology to molecular approach. Haematologica 97:1786–1794
D’Alcamo E, Agrigento V, Sclafani S, Vitrano A, Cuccia L, Maggio A, Perrotta S, Capra M, Rigano P (2011) Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematologica, 125(3):136–140, 1421–96621
Heimpel H et al (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107:334–340
Dukka S, King MJ, Hill QA (2014) The diagnostic challenge of congenital dyserythropoietic anaemia: two cases of ‘CDA type II’. J Clin Pathol 67(4):367–369
Renella R, Roberts NA, Brown JM, De Gobbi M, Bird LE, Hassanali T et al (2011) Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1 alpha localization in erythroblasts. Blood 117:6928–6938
Ask K, Jasencakova Z, Menard P, Feng Y, Almouzni G, Groth A (2012) Codanin-1 mutated in the anaemic disease CDA1 regulates Asf1 function in S-phase histone supply. EMBO J 31(8):2013–2022
Galanello R, Perseu L, Satta S, De Martis FR, Campus S (2011) Phenotype–genotype correlation in beta-Thalassemia. Thalassemia Rep 1(s2):e6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D’Alcamo, E., Agrigento, V., Pitrolo, L. et al. New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia. Indian J Hematol Blood Transfus 32 (Suppl 1), 278–281 (2016). https://doi.org/10.1007/s12288-015-0633-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0633-z